Long-term Outcomes with Everolimus Following Calcineurin Inhibitor Withdrawal: Data from the H2304 and PROTECT Extension Studies

被引：0
|
作者：
Fischer, L. [1 ,2 ]
Fung, J. [1 ]
Metselaar, H. J. [1 ]
Kaiser, G. [1 ,2 ]
Schemmer, P. [2 ]
Neuhaus, P. [2 ]
Dong, G. [3 ]
Lopez, P. [4 ]
Bernhardt, P. [4 ]
Schlitt, H. J. [2 ]
机构：
[1] H2304 Study Grp, Hamburg, Germany
[2] PROTECT Study Grp, Hamburg, Germany
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Novartis Pharma AG, Basel, Switzerland
来源：
TRANSPLANTATION | 2016年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
O-26
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [1] EVALUATION OF THE LONG-TERM OUTCOMES WITH EVEROLIMUS, AFTER CALCINEURIN INHIBITOR WITHDRAWAL: 36 M RESULTS OF THE H2304 AND PROTECT EXTENSION STUDIES
    Fischer, L.
    Fung, J.
    Metselaar, H. J.
    Kaiser, G.
    Schemmer, P.
    Neuhaus, P.
    Kroeger, I.
    Lopez, P.
    Bernhardt, P.
    Schlitt, H. -J.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 9 - 10
  • [2] Evaluation of the Long-Term Outcomes with Everolimus After Calcineurin Inhibitor Withdrawal: 36M Results of the H2304 and PROTECT Extension Studies
    Fischer, L.
    Fung, J.
    Metselaar, H.
    Kaiser, G.
    Schemmer, P.
    Neuhaus, P.
    Dong, G.
    Lopez, P.
    Bernhardt, P.
    Schlitt, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 254 - 255
  • [3] Long-term clinical outcomes evaluation of everolimus in liver transplant patients with autoimmune liver diseases: Pooled analysis from the H2304 and PROTECT trials
    Fung, John
    Charlton, Michael
    Saliba, Faouzi
    Schlitt, Hans J.
    Mccague, Kevin
    Junge, Guido
    Lopez, Patricia M.
    Patel, Dharmesh
    Sterneck, Martina R.
    HEPATOLOGY, 2017, 66 : 899A - 899A
  • [4] Long-Term Superior Renal Function With Everolimus and Reduced Tacrolimus in Liver Transplant Recipients: 3-Year Results from the H2304 Extension Study
    Fischer, Lutz
    Saliba, Faouzi
    Kaiser, Gernot M.
    De Carlis, Luciano
    Metselaar, Herold J.
    Nevens, Frederik
    Duvoux, Christophe
    Dong, Gaohong
    Rauer, Barbara
    Junge, Guido
    LIVER TRANSPLANTATION, 2014, 20 : S171 - S172
  • [5] Long-Term Safety With Everolimus-Based Regimen in De Novo Liver Transplant Recipients: 4-Year Results From The Extension of H2304 Study.
    Saliba, F.
    Rogiers, X.
    Chapman, W.
    Caicedo, L.
    Alsina, A.
    Teperman, L.
    Junge, G.
    Rauer, B.
    Dong, G.
    De Simone, P.
    TRANSPLANTATION, 2014, 98 : 161 - 161
  • [6] Assessment of Cardiovascular Disease Risk in Liver Transplant Recipients with Everolimus-Based Calcineurin Inhibitor Reduction or Withdrawal Regimen: A 3-Year Post-Hoc Analysis from the Randomized H2304 Extension Study
    Bernhardt, Peter
    Dong, Gaohong
    Lopez, Patricia
    Hustache, Gregory
    Bader, Giovanni
    TRANSPLANTATION, 2016, 100 : S81 - S81
  • [7] Long-Term Safety With Everolimus-Based Regimen in De Novo Liver Transplant Recipients: 4-Year Results From The Extension of H2304 Study.
    Saliba, F.
    Rogiers, X.
    Chapman, W.
    Caicedo, L.
    Alsina, A.
    Teperman, L.
    Junge, G.
    Rauer, B.
    Dong, G.
    De Simone, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 161 - 161
  • [8] Everolimus Monotherapy after Tacrolimus Withdrawal at Month 4 after Liver Transplantation: 3-Year Results from the H2304 Study Extension.
    Fung, J.
    Metselaar, H. J.
    Koneru, B.
    Bartels, M.
    McCaughan, G.
    Chavin, K.
    Dong, G.
    Rauer, B.
    Junge, G.
    Fischer, L.
    LIVER TRANSPLANTATION, 2014, 20 : S106 - S106
  • [9] Long-Term Outcomes of Calcineurin Inhibitor Withdrawal for Post-Liver Transplant Renal Dysfunction
    Mackay, A. J.
    Angus, P. W.
    Gow, P. J.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (10) : 3802 - 3806
  • [10] A 3-YEAR POST-HOC ANALYSIS OF THE RANDOMIZED H2304 EXTENSION STUDY EVALUATION OF THE MAJOR ADVERSE CARDIAC EVENTS RISK WITH EVEROLIMUS-BASED CALCINEURIN INHIBITOR REDUCTION OR WITHDRAWAL REGIMEN IN LIVER TRANSPLANT RECIPIENTS
    Bernhardt, P.
    Lopez, P.
    Kroeger, I.
    Hustache, G.
    Bader, G.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 21 - 21
12345